Credits - 30 / European ECTS credits

Pre-selection process: Open

Inscriptions Open: from June 2019 to January 2020

Postgraduate Program –  from the 3rd of February 2019 to the  28th of May 2019.

Full Time - Monday to Thursday from 18:00h. to 21:00h.

Language - English

Limited Places


The objective of the program is to acquire a specialized knowledge in health economics and market access to understand the global process of launching new compounds in different markets. The main skills and topics are related with global portfolios, definition, activities and budgeting in new drug developments, pricing, National Healthcare System and FDA and EMA Markets.

See the academic programme here


The students of our programs will have the opportunity to work in teams of some of the most important global pharmaceutical companies as well as new biotechnology companies, developing innovative products inside the biomedical sector. Their demanded profiles allow the students to work in different roles and departments in biotech companies, consultancies, pharmaceutical companies, technology transfer offices from hospitals and research centers. 


The Students that pass the postgraduate program  evaluation will receive a double titulation from the Univerisity of Barcelona and the Biotechnology Business Institute in Postgraduated in HEOR and Masket Access.



Information request